Our team is paving the way to this future by fusing innovative hardware with machine learning algorithms guided by expert knowledge of molecular spectroscopy. Our products are elegantly designed with a human touch to help you navigate complexity. Pendar’s platforms help identify and detect materials, determine optimal chemical reaction pathways, and perceive the health of a human organ. By providing clear actionable results and interpretations, our solutions enable users to focus on their primary objectives: discovering and scaling-up new chemistries, responding to emergencies, and saving lives.
Our team previously brought handheld spectroscopy to the field, founded two successful venture-backed companies, and pioneered Quantum Cascade Lasers (QCLs). We are a vertically integrated company of scientists, engineers, and innovators building our own software, spectroscopy platforms, and laser systems from the ground-up. Pendar’s solutions leverage our core capabilities into uniquely insightful products for the pharmaceutical, safety & security, and medical markets. Pendar Technologies was formed in 2015 by a merger of Pendar Medical and Eos Photonics (founded by Christian Pfluegl, Laurent Diehl, Mark F. Witinski, and Federico Capasso).